FDA Approval Activities for this Drug…

Hectorol (Doxercalciferol) Capsules, 2.5 mcg, Bone Care International NDA 20-862 6/9/99 6/11/99 6/11/99 6/29/00 Hectorol Indication:For the reduction of elevated iPTH levels in the management of secondary hyperparathyroidism in patients undergoing chronic renal dialysis. Hectorol IV, Bone Care International NDA 21-027 Hectorol (doxercalciferol) Injection, Bone Care International Hectorol (Doxercalciferol) Capsules, Bone Care International | Hectorol (doxercalciferol) Capsules, Bone Care Intl., Labeling Revision

For the latest approval information, please locate this drug using this index.